Bright Health Group, Inc.
NYSE:BHG
16.35 (USD) • At close January 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 292.871 | 269.399 | 297.982 | 756.341 | 551.425 | 1,632.292 | 1,576.628 | 1,835.575 | 962.334 | 1,078.657 | 1,113.84 | 874.558 | 359.778 | 352.12 | 296.856 | 198.566 |
| Cost of Revenue
| 330.305 | 226.438 | 245.16 | 688.515 | 519.291 | 1,456.862 | 1,398.166 | 1,580.596 | 2,604.659 | 1,050.943 | 904.63 | 684.57 | 372.186 | 311.319 | 233.18 | 130.615 |
| Gross Profit
| -37.434 | 42.961 | 52.822 | 67.826 | 32.134 | 175.43 | 178.462 | 254.979 | -1,642.325 | 27.714 | 209.21 | 189.988 | -12.408 | 40.801 | 63.676 | 67.951 |
| Gross Profit Ratio
| -0.128 | 0.159 | 0.177 | 0.09 | 0.058 | 0.107 | 0.113 | 0.139 | -1.707 | 0.026 | 0.188 | 0.217 | -0.034 | 0.116 | 0.215 | 0.342 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 65.94 | 63.95 | 108.869 | -173.456 | 221.904 | 213.805 | 239.588 | 248.644 | 161.545 | 119.682 | 96.489 | 65.779 | 56.333 | 46.871 | 42.766 |
| Selling & Marketing Expenses
| 0 | 0.258 | 0.63 | 20.344 | -167.118 | 77.721 | 79.93 | 91.807 | 104.119 | 69.443 | 63.988 | 50.205 | 57.886 | 15.941 | 14.474 | 8.64 |
| SG&A
| 0 | 66.198 | 64.58 | 129.213 | -340.574 | 299.625 | 293.735 | 331.395 | 352.763 | 230.988 | 183.67 | 146.694 | 123.665 | 72.274 | 61.345 | 51.406 |
| Other Expenses
| 338.806 | 732.174 | 321.396 | 21.002 | 536.707 | 11.724 | 132.814 | 100.564 | 1,782.331 | 1.226 | 84.585 | 66.127 | 27.758 | 27.783 | 29.567 | 23.825 |
| Operating Expenses
| 338.806 | 99.07 | 74.951 | 150.215 | 196.133 | 311.349 | 426.549 | 431.959 | 1,782.331 | 323.995 | 268.255 | 212.821 | 151.423 | 100.057 | 90.912 | 75.231 |
| Operating Income
| -62.827 | -462.775 | -23.414 | -82.389 | -163.999 | -135.919 | -248.087 | -176.98 | -819.997 | -296.281 | -59.045 | -22.833 | -163.831 | -59.256 | -27.236 | -7.28 |
| Operating Income Ratio
| -0.215 | -1.718 | -0.079 | -0.109 | -0.297 | -0.083 | -0.157 | -0.096 | -0.852 | -0.275 | -0.053 | -0.026 | -0.455 | -0.168 | -0.092 | -0.037 |
| Total Other Income Expenses Net
| -2.073 | -426.581 | -0.892 | 1.259 | -115.483 | -121.679 | -179.7 | -80.569 | -856.903 | -0.368 | -4.142 | -0.546 | -3.8 | 0 | 0 | 0 |
| Income Before Tax
| -61.237 | -482.69 | -32.584 | -93.533 | -192.462 | -257.598 | -248.426 | -177.389 | -821.671 | -296.649 | -63.187 | -23.379 | -163.831 | -59.256 | -27.236 | -7.28 |
| Income Before Tax Ratio
| -0.209 | -1.792 | -0.109 | -0.124 | -0.349 | -0.158 | -0.158 | -0.097 | -0.854 | -0.275 | -0.057 | -0.027 | -0.455 | -0.168 | -0.092 | -0.037 |
| Income Tax Expense
| 1.59 | -3.385 | -0.892 | 1.259 | -4.228 | 1.763 | 2.904 | 3.24 | -8.296 | 0.073 | -19.464 | 1.166 | 0.001 | 0 | -9.162 | 3.009 |
| Net Income
| -242.332 | -633.895 | -112.832 | -94.792 | -188.234 | -259.361 | -251.33 | -180.629 | -813.375 | -300.664 | -44.518 | -25.162 | -163.832 | -59.256 | -18.074 | -7.28 |
| Net Income Ratio
| -0.827 | -2.353 | -0.379 | -0.125 | -0.341 | -0.159 | -0.159 | -0.098 | -0.845 | -0.279 | -0.04 | -0.029 | -0.455 | -0.168 | -0.061 | -0.037 |
| EPS
| -30.47 | -79.47 | -14.17 | -12.01 | -23.97 | -32.95 | -31.96 | -22.98 | 27.65 | -38.16 | -22.13 | -14.36 | -95.67 | -34.77 | -10.65 | -4.25 |
| EPS Diluted
| -30.47 | -79.47 | -14.17 | -12.01 | -23.97 | -32.95 | -31.96 | -22.98 | 27.65 | -38.16 | -22.13 | -14.36 | -95.67 | -34.77 | -10.65 | -4.25 |
| EBITDA
| -225.512 | -51.986 | -15.994 | -72.498 | -153.597 | -122.013 | -234.86 | -163.155 | -810.494 | -280.85 | -51.85 | -18.252 | -161.092 | -56.578 | -25.151 | -6.493 |
| EBITDA Ratio
| -0.77 | -0.193 | -0.054 | -0.096 | -0.279 | -0.075 | -0.149 | -0.089 | -0.842 | -0.26 | -0.047 | -0.021 | -0.448 | -0.161 | -0.085 | -0.033 |